A new research study suggests that Trazodone, a drug formerly used to treat depression could have a positive effect on neurodegenerative brain diseases, including Parkinson’s disease.

The study was led by Professor Giovanna Mallucci, at the Medical Research Council’s Toxicology Unit in Leicester and Cambridge University.

Dr Richard Wyse, Director of Research and Development commented: “The Cure Parkinson’s Trust has been exploring Trazodone since July 2016 through its Linked Clinical Trials initiative, a programme that is specifically designed to move pre-approved drugs into clinical trial with urgency. The Linked Clinical Trials committee will continue to evaluate this compound with a view to fast-tracking it into clinical trials in people with Parkinson’s as soon as possible."

Further reading here